These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36566931)
1. Achievement of glycemic control and antidepressant medication use in comorbid depression and type 2 diabetes. Brieler JA; Salas J; Keegan-Garrett E; Scherrer JF J Affect Disord; 2023 Mar; 324():1-7. PubMed ID: 36566931 [TBL] [Abstract][Full Text] [Related]
2. Achievement of glycemic control and antidepressant medication use in comorbid depression and type II diabetes. Brieler J; Salas J; Scherrer J Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35947421 [TBL] [Abstract][Full Text] [Related]
3. The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA Rohde C; Knudsen JS; Schmitz N; Østergaard SD; Thomsen RW Diabetologia; 2021 Feb; 64(2):361-374. PubMed ID: 33073329 [TBL] [Abstract][Full Text] [Related]
4. The association between antidepressant use and glycemic control in the Southern Community Cohort Study (SCCS). Kammer JR; Hosler AS; Leckman-Westin E; DiRienzo G; Osborn CY J Diabetes Complications; 2016 Mar; 30(2):242-7. PubMed ID: 26615906 [TBL] [Abstract][Full Text] [Related]
6. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING. Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044 [TBL] [Abstract][Full Text] [Related]
7. Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis. Chow W; Miyasato G; Kokkotos FK; Bailey RA; Buysman EK; Henk HJ Clin Ther; 2016 Sep; 38(9):2071-82. PubMed ID: 27596020 [TBL] [Abstract][Full Text] [Related]
8. Greater Glycemic Burden Is Associated with Further Poorer Glycemic Control in Newly-Diagnosed Type 2 Diabetes Mellitus Patients. Wen WL; Huang HC; Lin HC; Lo WC; Chen SC; Lee MY Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057503 [No Abstract] [Full Text] [Related]
9. Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database. Aronson R; Orzech N; Ye C; Goldenberg R; Brown V J Diabetes; 2016 Jan; 8(1):76-85. PubMed ID: 25565383 [TBL] [Abstract][Full Text] [Related]
10. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder. Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095 [TBL] [Abstract][Full Text] [Related]
11. Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years. Gotfredsen DR; Vinther S; Petersen TS; Cortes R; Jensen TB; Jimenez-Solem E; Christensen MB Sci Rep; 2020 Mar; 10(1):4095. PubMed ID: 32139733 [TBL] [Abstract][Full Text] [Related]
12. Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Lin C; Cai X; Yang W; Lv F; Nie L; Ji L Endocrine; 2020 Nov; 70(2):232-242. PubMed ID: 32533507 [TBL] [Abstract][Full Text] [Related]
13. Anxious depression in patients with Type 2 Diabetes Mellitus and its relationship with medication adherence and glycemic control. Gonzalez Heredia T; González-Ramírez LP; Hernández-Corona DM; Maciel-Hernández EA Glob Public Health; 2021 Mar; 16(3):460-468. PubMed ID: 32841093 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT. Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135 [TBL] [Abstract][Full Text] [Related]
15. Psychological distress, self-efficacy and glycemic control in type 2 diabetes. Indelicato L; Dauriz M; Santi L; Bonora F; Negri C; Cacciatori V; Targher G; Trento M; Bonora E Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):300-306. PubMed ID: 28274728 [TBL] [Abstract][Full Text] [Related]
16. The association between antidepressant treatment and rates of insulin initiation in comorbid depression and type 2 diabetes: A UK electronic health record nested case-control study. Jeffery A; Walters K; Wong ICK; Osborn D; Hayes JF Diabetes Res Clin Pract; 2024 Mar; 209():111083. PubMed ID: 38159576 [TBL] [Abstract][Full Text] [Related]
17. Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study. Jeffery A; Bhanu C; Walters K; Wong ICK; Osborn D; Hayes JF Br J Psychiatry; 2023 Mar; 222(3):112-118. PubMed ID: 36451601 [TBL] [Abstract][Full Text] [Related]
18. Association Between the Use of Antidepressants and the Risk of Type 2 Diabetes: A Large, Population-Based Cohort Study in Japan. Miidera H; Enomoto M; Kitamura S; Tachimori H; Mishima K Diabetes Care; 2020 Apr; 43(4):885-893. PubMed ID: 32051242 [TBL] [Abstract][Full Text] [Related]
19. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents. Vinik AI; Cincotta AH; Scranton RE; Bohannon N; Ezrokhi M; Gaziano JM Endocr Pract; 2012; 18(6):931-43. PubMed ID: 23186965 [TBL] [Abstract][Full Text] [Related]
20. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications. Nau DP; Chao J; Aikens JE Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]